BIVIW

BIOVIE INC.

BIVIW · CIK 1580149 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20172025
Net Income−$18M
20172025
Operating CF−$19M
20172025
Free Cash Flow
20172025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017
Revenue
Cost of Revenue
Gross Profit
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
SG&A Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.1B$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-12.12$-7.30$-1.55$-1.06$-14.82$-6.85
EPS (Diluted)$-12.12$-7.30$-1.55$-1.06$-14.82$-6.85

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$-0.0B$0.0B
Capital Expenditures
Financing Cash Flow$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B